Edition:
India

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

3.75USD
31 Jul 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.75
Open
--
Day's High
--
Day's Low
--
Volume
15
Avg. Vol
333,470
52-wk High
$12.51
52-wk Low
$2.55

Latest Key Developments (Source: Significant Developments)

Zynerba Pharmaceuticals Inc Files For Mixed Shelf Of Upto $300 Million
Tuesday, 6 Aug 2019 

Aug 6 (Reuters) - Zynerba Pharmaceuticals Inc ::ZYNERBA PHARMACEUTICALS INC FILES FOR MIXED SHELF OF UPTO $300 MILLION - SEC FILING.  Full Article

Zynerba Pharmaceuticals Q4 Loss Per Share $0.44
Monday, 11 Mar 2019 

March 11 (Reuters) - Zynerba Pharmaceuticals Inc ::ZYNERBA PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR END 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS.Q4 LOSS PER SHARE $0.44.Q4 EARNINGS PER SHARE ESTIMATE $-0.65 -- REFINITIV IBES DATA.ZYNERBA PHARMACEUTICALS - ANNOUNCED THAT CURRENT CASH & CASH EQUIVALENT POSITION IS EXPECTED TO FUND OPERATIONS & CAPITAL REQUIREMENTS INTO Q1 OF 2021.AS OF DEC 31, 2018, CASH AND CASH EQUIVALENTS WERE $59.8 MILLION, COMPARED TO $62.5 MILLION AS OF DECEMBER 31, 2017.  Full Article

Zynerba's cannabis-based drug for rare genetic disorder fails study

Zynerba Pharmaceuticals Inc said on Tuesday its experimental cannabis-based gel Zygel was not statistically significant in improving aberrant behavior when compared to a placebo in patients with a neurological disorder called Fragile X syndrome.